[NEJM] Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes

Divyanshu Post time 7 day(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-09-11 17:00
Reward10points

journal:New England Journal of Medicine

Authors:Darren K. McGuire; Nikolaus Marx; Sharon L. Mulvagh; John E. Deanfield; Silvio E. Inzucchi; Rodica Pop-Busui; Johannes F.E. Mann; Scott S. Emerson; Neil R. Poulter; Mads D.M. Engelmann; Maria Sejersten Ripa; G. Kees Hovingh; Kirstine Brown-Frandsen; Stephen C. Bain; Matthew A. Cavender; Mette Gislum; Jens-Peter David; John B. Buse

Published date:2025-5-29

DOI:10.1056/nejmoa2501006

PDF link:http://www.nejm.org/doi/pdf/10.1056/NEJMoa2501006

Article link:https://doi.org/10.1056/nejmoa2501006

Article Source:Massachusetts Medical Society


Remark:

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Georgee Post time 7 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list